Navigation Links
Graft-versus-Host Diseases can Be Predicted

Human-to-human organ transplantation saves and enhances the lives of a number of patients suffering from many forms of end-stage organ failure//. Today, transplantation is the leading form of treatment for several debilitating diseases.

Graft-versus-host disease occurs when white blood cells from the donor attack tissues of the recipient. It is a very serious complication after stem cell transplantation from related or unrelated donors and may represent a cause of death in 30 to 50 percent of patients.

Graft-versus-host disease is a complication of allogeneic hematopoietic cell transplantation, which results from recognition of recipient antigens by immune T cells from the donor.

Two papers published this week investigate how graft versus host disease might be predicted after hematopoietic cell transplantation.

In the first paper “Prediction of Graft-Versus-Host Disease by Gene-Expression Profiling of Donors” Claude Perreault and colleagues from the University of Montreal tested whether some donors may react more strongly against recipient cells than others. Using microarrays, they measured the gene-expression profiles of CD4+ and CD8+ T cells from 50 donors and were able to show that donor gene-expression profile in these cells had a strong influence on the occurrence of graft-versus-host disease in the recipient.

Source-Eurekalert
PR
'"/>




Page: 1

Related medicine news :

1. In Chronic Diseases - Poor compliance of Patients with drug treatment
2. ICMR along with other International Research organisation with drug development for Neglected Diseases
3. Chronic Diseases said to Cause Falls in the Elderly
4. Viagra Also Found To Be Effective For Treatment of Lung Diseases
5. The Drug Tetrathiomolybdate Found To Be Useful For Various Diseases
6. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
7. New Diseases
8. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
9. Controlled Gene Expressions Can Cure Many Diseases
10. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
11. Digoxin Pill To Fight Against Both Heart Diseases And Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society ... Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... Foundation, a not-for-profit organization responsible for clinical transfusion research programs and for the ... the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. ... mobile security software, is featured in the current issue of Silicon Review ... companies with innovative technology solutions and features them in their magazine. The magazine ...
(Date:6/23/2016)... Newark, NJ (PRWEB) , ... June 23, 2016 ... ... declared today’s Appellate Court ruling a victory for consumers seeking relief from the ... Div., Docket No. A2913-15T2 & A2929-15T2. , In their ruling ( ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... A key ... DC area, which is one of the best known examples of areas that lack ... amassed almost a thousand daily users. , Any participant within the marijuana industry, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology: